Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Signs HGP Contract; Links Expression Product With Spotfire’s Software

Premium

PALO ALTO, Calif.--Incyte Pharmaceuticals said it has finalized an agreement to contribute to the Human Genome Project by performing DNA sequencing for the University of Washington. The university, which named Incyte as a collaborator in a grant proposal it made to the US National Human Genome Research Institute earlier this year, will refine the data Incyte generates and deposit it to GenBank. The university had requested $3 million to budget for Incyte’s sequencing services.

Incyte last week also announced that it would link its LifeArray gene expression software with Spotfire’s Decision Support Software. The combined product is designed to enable researchers to perform detailed visual analysis of gene expression data and to integrate results across multiple scientific or patent databases.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.